Intelligence · Clinical Pipeline
First People's Hospital Pipeline
All ClinicalTrials.gov programs at First People's Hospital — phase, modality, and trial IDs.
- Programs
- 1,136
Quick answer
First People's Hospital has 1,136 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Drug
The First People's Hospital of Lianyungang
Herpes Zoster
1 trial -
Drugs and Stimulation
The First People's Hospital of Lianyungang
Hearing Loss, Sudden
1 trial -
Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc
The First People's Hospital of Lianyungang
Diabetes
1 trial -
Dynamometric tension assessment
The First People's Hospital of Lianyungang
Incisional Hernia
1 trial -
EPCs plus PTA
The First People's Hospital of Lianyungang
Diabetic Foot
1 trial -
Efgartigimod + Telitacicept (1-week interval) group
The First People's Hospital of Lianyungang
Myasthenia Gravis
1 trial -
Entecavir 0.5 mg
The First People's Hospital of Lianyungang
Hepatitis B
1 trial -
Escitalopram Oxalate Tablets
The First People's Hospital of Lianyungang
Major Depressive Disorder
1 trial -
Esketamine
The First People's Hospital of Lianyungang
Post Induction Hypotension
1 trial -
Esketamine
The First People's Hospital of Lianyungang
Postoperative Cognitive Dysfunction
1 trial -
Esketamine at low dose
The First People's Hospital of Lianyungang
Insomnia
1 trial -
Experimental group
The First People's Hospital of Lianyungang
Overweight or Obesity
1 trial -
Favipiravir
The First People's Hospital of Lianyungang
COVID-19
1 trial -
Febuxostat
The First People's Hospital of Lianyungang
Refractory Gout
1 trial -
Fei Re Qing Granules
The First People's Hospital of Lianyungang
Severe Pneumonia Caused by Multidrug-resistant Gram-negative Bacterial Infection
1 trial -
Forced administration of furosemide
The First People's Hospital of Lianyungang
Cytoreductive Surgery
1 trial -
Fruquintinib and Everolimus
The First People's Hospital of Lianyungang
Renal Cell Carcinoma, Clear Cell, Somatic
1 trial -
G-CSF (Granulocyte colony-stimulating factor)
The First People's Hospital of Lianyungang
Granulocyte Colony-Stimulating Factor (G-CSF) Mobilization
1 trial -
GD007 Low-dose drug group
The First People's Hospital of Lianyungang
Moderate-Severe Intrauterine Adhesions
1 trial -
GDMT
The First People's Hospital of Lianyungang
Heart Failure With Preserved Ejection Fraction
1 trial -
Gastrodin Injection
The First People's Hospital of Lianyungang
Sensorineural Hearing Loss
1 trial -
Gemcitabine, cisplatin
The First People's Hospital of Lianyungang
Bladder Cancer
1 trial -
Ginkgo Biloba Extract
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
GnRH-a
The First People's Hospital of Lianyungang
Infertility, Female
1 trial -
GnRH-a
The First People's Hospital of Lianyungang
Clinical Pregnancy Rate
1 trial -
GnRH-a-1M
The First People's Hospital of Lianyungang
Adenomyosis of Uterus
1 trial -
GnRHa
The First People's Hospital of Lianyungang
Cesarean Scar Diverticula
1 trial -
Goserelin
The First People's Hospital of Lianyungang
Allogeneic Haematopoietic Stem Cell Transplantation
1 trial -
Guideline-directed medical therapy
The First People's Hospital of Lianyungang
Heart Failure With Reduced Ejection Fraction
1 trial -
HG204
The First People's Hospital of Lianyungang
MECP2 Duplication Syndrome
1 trial -
Health education and conservative management of clinical routines
The First People's Hospital of Lianyungang
Recurrent Acute Pancreatitis
1 trial -
HellenCare
The First People's Hospital of Lianyungang
Alzheimer's Disease Dementia
1 trial -
Heparin Sodium
The First People's Hospital of Lianyungang
Cerebral Aneurysm
1 trial -
High risk experimental group
The First People's Hospital of Lianyungang
Adolescent Idiopathic Scoliosis
1 trial -
High-dose vitamin D2 softgels
The First People's Hospital of Lianyungang
Chronic Kidney Disease 5D
1 trial -
Huang-long Zhi-xiao Granule
The First People's Hospital of Lianyungang
Asthma Chronic
1 trial -
Huangqi Guizhi Wuwu decoction
The First People's Hospital of Lianyungang
Diabetic Nephropathies
1 trial -
Hydrochlorothiazide, Captopril, Nitrendipine, Aspirin
The First People's Hospital of Lianyungang
Hypertension
1 trial -
Hypofractionated Radiation Therapy
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
IORT
The First People's Hospital of Lianyungang
Laryngeal Neoplasms
1 trial -
IPT plus HD-tDCS
The First People's Hospital of Lianyungang
Depressive Disorder
1 trial -
Indometacin suppository
The First People's Hospital of Lianyungang
Pancreatitis, Chronic
1 trial -
Induction therapy-2 cycles of VPX (Teniposide, PD-1 monoclonal antibody plus Selinixor)
The First People's Hospital of Lianyungang
Primary Central Nervous System Lymphoma (PCNSL)
1 trial -
Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide)
The First People's Hospital of Lianyungang
CD30+ Peripheral T-cell Lymphoma
1 trial -
Induction therapy-Pro regimen
The First People's Hospital of Lianyungang
Diffuse Large B-Cell Lymphoma
1 trial -
Influence of propofol sedation on memory consolidation and 'working memory'
The First People's Hospital of Lianyungang
Memory Impairment
1 trial -
Infrared thermography
The First People's Hospital of Lianyungang
Chronic Obstructive Pulmonary Disease
1 trial -
Insulin
The First People's Hospital of Lianyungang
Gestational Diabetes
1 trial
Frequently asked questions
How many pipeline programs does First People's Hospital have?
1,136 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs